FIXIX | IRCYX | FIXIX / IRCYX | |
Total Expense Ratio | 1.04 | 1.07 | 97% |
Annual Report Gross Expense Ratio | 1.04 | 1.07 | 97% |
Fund Existence | 22 years | 10 years | - |
Gain YTD | 21.519 | 27.607 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.07B | 1.17B | 435% |
Annual Yield % from dividends | 2.21 | 2.19 | 101% |
Returns for 1 year | 15.02 | 24.49 | 61% |
Returns for 3 years | 41.95 | 49.03 | 86% |
Returns for 5 years | 56.71 | 56.51 | 100% |
Returns for 10 years | 67.83 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 131.35 | 1.59 | +1.23% |
Franklin Biotechnology Discovery A | |||
STCAX | 17.33 | -0.04 | -0.23% |
Virtus Silvant Large-Cap Growth Stk I | |||
PRVIX | 53.38 | -0.23 | -0.43% |
T. Rowe Price Small-Cap Value I | |||
PLLAX | 27.35 | -0.12 | -0.44% |
Principal SmallCap A | |||
GCSVX | 9.75 | -0.06 | -0.61% |
Geneva SMID Cap Growth Institutional |